NeoPharm, Akzo Nobel NV deal

AKZOY's Diosynth Biotechnology subsidiary (Research Triangle Park, N.C.) and NEOL amended a 2004 deal under which Diosynth is manufacturing NEOL's cintredekin besudotox (IL13-PE38QQR) for a Phase III ...